Literature DB >> 2456838

Nucleus cuneiformis and pain modulation: anatomy and behavioral pharmacology.

F P Zemlan1, M M Behbehani.   

Abstract

The anatomical substrate and behavioral pharmacology of stimulation-produced analgesia resulting from electrical stimulation of the pontomesencephalic nucleus cuneiformis (NCF) was determined in the present study. Maximum increase in nociceptive tail-flick latencies following NCF stimulation occurred during the first 5 min post stimulation and decreased afterwards. The increased reflex latency could be attenuated by prior treatment with the narcotic antagonist, naloxone or the cholinergic antagonist, scopolamine. The anatomical projections of NCF were identified in autoradiographic and histochemical studies. Ipsilateral fibers coursed caudal from the NCF injection site through the ventral pontine reticular formation to innervate nucleus raphe magnus and the ipsilateral nucleus magnocellularis. At rostral medullary levels fibers coursed dorsolateral to innervate the ipsilateral nucleus reticularis parvocellularis. Descending contralateral fibers crossed through the decussation of the superior cerebellar peduncle, then coursed ventrolaterally projecting to the contralateral nucleus magnocellularis. Two primary groups of ascending fibers were observed. The dorsally located group ascended through the central tegmental tract projecting to the dorsal raphe, ipsilateral periaqueductal gray, nucleus parafascicularis and centromedianus, the intermediolateral and lateral thalamic nuclei. The ventral group coursed ventrolateral from the injection site projecting to the substantia nigra, zona compacta, ventral tegmental area of Tsai, zona incerta, Fields of Forel, lateral hypothalamic nucleus and nucleus reuniens. These anatomic and behavioral data suggest that NCF plays an important role in sensory/motor integration relevant to pain transmission.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456838     DOI: 10.1016/0006-8993(88)90146-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  16 in total

1.  Central neurophysiologic mechanisms of the regulation of inhibition.

Authors:  S K Verevkina; A D Nozdrachev
Journal:  Neurosci Behav Physiol       Date:  1991 May-Jun

2.  Brain circuits mediating baroreflex bradycardia inhibition in rats: an anatomical and functional link between the cuneiform nucleus and the periaqueductal grey.

Authors:  Florence Netzer; Jean-François Bernard; Anthony J M Verberne; Michel Hamon; Françoise Camus; Jean-Jacques Benoliel; Caroline Sévoz-Couche
Journal:  J Physiol       Date:  2011-02-21       Impact factor: 5.182

3.  Cuneiform neurons activated during cholinergically induced active sleep in the cat.

Authors:  I Pose; S Sampogna; M H Chase; F R Morales
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

4.  Melanocortin-4 receptor expression in the cuneiform nucleus is involved in modulation of opioidergic signaling.

Authors:  Yong-Tang Song; Tao-Tao Liu; Li Feng; Tao Zhang; Hong-Bing Xiang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

5.  Output pathways from the rat superior colliculus mediating approach and avoidance have different sensory properties.

Authors:  G W Westby; K A Keay; P Redgrave; P Dean; M Bannister
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

6.  A Brainstem-Spinal Cord Inhibitory Circuit for Mechanical Pain Modulation by GABA and Enkephalins.

Authors:  Amaury François; Sarah A Low; Elizabeth I Sypek; Amelia J Christensen; Chaudy Sotoudeh; Kevin T Beier; Charu Ramakrishnan; Kimberly D Ritola; Reza Sharif-Naeini; Karl Deisseroth; Scott L Delp; Robert C Malenka; Liqun Luo; Adam W Hantman; Grégory Scherrer
Journal:  Neuron       Date:  2017-02-02       Impact factor: 17.173

7.  Projections from the rat cuneiform nucleus to the A7, A6 (locus coeruleus), and A5 pontine noradrenergic cell groups.

Authors:  Dusica Bajic; Herbert K Proudfit
Journal:  J Chem Neuroanat       Date:  2013-03-20       Impact factor: 3.052

8.  Decrease of gray matter volume in the midbrain is associated with treatment response in medication-overuse headache: possible influence of orbitofrontal cortex.

Authors:  Franz Riederer; Andreas R Gantenbein; Marvin Marti; Roger Luechinger; Spyridon Kollias; Peter S Sándor
Journal:  J Neurosci       Date:  2013-09-25       Impact factor: 6.167

9.  Brain Activity Unique to Orgasm in Women: An fMRI Analysis.

Authors:  Nan J Wise; Eleni Frangos; Barry R Komisaruk
Journal:  J Sex Med       Date:  2017-10-03       Impact factor: 3.802

10.  Neural correlates of an injury-free model of central sensitization induced by opioid withdrawal in humans.

Authors:  Vishvarani Wanigasekera; Michael C H Lee; Richard Rogers; Philip Hu; Irene Tracey
Journal:  J Neurosci       Date:  2011-02-23       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.